跳至主要内容
临床试验/IRCT20220404054403N1
IRCT20220404054403N1尚未招募3 期

Effect of 25 and 100 mg spironolactone on quality of life, ejection fraction and readmission in systolic heart failure patients with reduced ejection fraction in Imam Khomeini hospital in Ahvaz

Ahvaz University of Medical Sciences0 个研究点目标入组 94 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
94

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Acute systolic heart failure (EF <40)
  • A history of hospitalization in the last 6 months

排除标准

  • Known contraindications for spironolactone or prior documented intolerance  to an aldosterone receptor antagonist
  • Significant laboratory abnormalities (potassium = 5.1 mmol)
  • Mental disorders suspected to interact with study outcome
  • Pregnant or nursing women
  • Significant renal dysfunction
  • Significant hypotension (lower than 90 mm Hg systolic or 60 mm Hg diastolic)

研究者

相似试验